Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for induction therapy in living donor renal transplantation
2009-017066-23Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of rituximab in end-stage kidney disease (ESKD) and kidney allograft rejection (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: eGFR at 12 months. Status: unknown.
02
Drugs
rituximab
03
Conditions
end-stage kidney disease (ESKD)kidney allograft rejection
Beyond the preview
Go deeper on 2009-017066-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017066-23.